NACLC 2022

Call for Abstracts

Call for Abstracts

The Scientific Program Committee for the IASLC 2022 North America Conference on Lung Cancer is inviting the submission of scientific abstracts. Please read the details below carefully before submitting an abstract. 

Important Deadlines

May 16, 2022Abstract Submission Opens
June 17, 2022 (23:59 PST) Abstract Submission Deadline
July 22, 2022Abstract Notifications of Acceptance/Rejection
August 19, 2022 Presenting Author Registration Deadline
  • Oral Presentation (a maximum of four oral presentations will be selected, if you are not comfortable providing an oral presentation please only select poster presentation during submission)
  • Poster Presentation (abstracts not selected for oral presentation will be provided a poster presentation)
  • Community Practice
  • Medical Oncology
  • Mesothelioma/Other Thoracic Malignancies
  • Nursing & Allied Health
  • Pathology
  • Patient Advocacy
  • Tobacco Control, Environmental Exposure, Risk Reduction Screening
  • Pulmonology
  • Radiation Oncology
  • Surgery
  • Translational Science
  • Research work should be original and innovative. Work can be presented prior to the IASLC 2022 North America Conference on Lung Cancer Meeting but MUST include new information/data.
  • Abstract title must not exceed 100 characters in length.
  • Abstracts must not exceed 400 words in length (not including title and authors).
  • Tables may be included, and each will count as 100 words.
  • A maximum of two images may be included; each will count as 100 words.
  • Tables, images and graphs must be uploaded in GIF, JPEG, JPG or PNG format at 300 dpi and 100% size. Any higher resolution is acceptable.
  • Abstracts must be structured with the following headings:
    • Background
    • Methods
    • Results
    • Conclusion
  • Please add the above headings (Background, Methods, Results, Conclusion) to each section of your abstract body.
  • Abstracts will be accepted in English only.
  • There is no fee for submitting an abstract.
  • There is no limit to the number of abstracts you may submit (however an individual may not be offered more than one poster or oral presentation).
  • Special consideration will be given to authors < 4 years from completion of fellowship training (no proof required).
  • Encore Submission: An abstract that has previously been presented at another meeting will only be considered if there have been significant updates to the abstract. Submitters are required to list any previously presented abstracts in the introduction of the abstract.
  • Trial in Progress: NACLC accepts the submissions of trials in progress.
  • Financial disclosure and affiliation information is required for the presenting author.
  • Publication: Authors must agree to allow publication of accepted abstract(s) in the Journal of Thoracic Oncology (JTO) and the conference website. Most abstracts will be published and released prior to the meeting, except for embargoed abstracts which will be posted on the day of presentation.
  • Definition: Plagiarism encompasses all of following: 
  1. Direct: intentionally submitting another person’s words or ideas verbatim as one’s own;
  2. Self-plagiarism: submitting work that has been previously published or presented;
  3. Mosaic plagiarism: stringing together portions of text from other sources; and
  4. Lack of attribution: failing to appropriately identify and cite sources for language or ideas that are incorporated.

For more information see: Das N, Panjabi M. Plagiarism: Why is it such a big issue for medical writers? Perspect Clin Res. 2011;2(2):67–71. doi:10.4103/2229-3485.80370

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121267/

  • Screening: IASLC screens all abstracts using anti-plagiarism software. Abstracts identified as having high levels of plagiarized content will be evaluated by IASLC staff and appropriate actions taken.
  • Penalties for plagiarism may include: Rejection of abstract, and/or author(s) banned from making presentations at IASLC conferences.

Independence of Educational Activity

  • Employees of ACCME defined ineligible companies are prohibited from presenting educational content for Continuing Medical Education. Consequently, employees of ineligible companies are prohibited from giving presentations during accredited CME sessions. 
  • In situations where the presenting author is an employee of an ineligible company, the abstract will automatically be considered for a poster. 
  • Presenting authors must be registered for NACLC 2022 independent of an ineligible company, except for employees of ineligible companies, who are allowed to be registered by their employers. 
  • Presenting author must control all content. Ineligible companies may not influence scientific content by requiring the use of company slide decks or other materials. Scientific data generated by industry sponsored research is permissible. 
  • Content of educational activities must be well-balanced, evidence based and unbiased. Generic names should be used to the extent possible. 
  • Ineligible companies/commercial interests may not submit registration materials or fees on behalf of learners, faculty or others attendee types.

Step 1. Title, Topic and Presentation Type

  • The abstract title must not exceed 100 characters in length.
  • Please select the desired topic for your abstract submission. The scientific program committee reserves the right to move the abstract to another topic should it be seen as a better fit.

Step 2. Authors

  • Please enter the authors and affiliations of the abstract in title case.
  • There is no limit to the number of co-authors per abstract.
  • There is a limit of one presenting author per abstract.
  • If more than two authors are listed, please select who the presenting author is.
  • The presenting author of an accepted abstract must be registered by August 19, 2022.
  • Should a presenting author not be registered by the deadline the abstract may be removed from the program.

Step 3. Abstract Text

  • Do not include Title or Author data in the body of your abstract. Title and author should be entered in the steps above.
  • Abstracts may be entered directly into the site or copied and pasted.
  • Research work should be original and innovative. Work can be presented prior to the IASLC 2022 North America Conference on Lung Cancer, but MUST include new information/data.
  • Abstracts must not exceed 400 words in length (not including title and authors).
  • Tables may be included, and each will count as 100 words.
  • A maximum of two images may be included; each will count as 100 words.
  • Tables, images and graphs must be uploaded in GIF, JPEG, JPG or PNG format at 300 dpi and 100% size. Any higher resolution is acceptable.
  • Abstracts must be structured with the following headings:
    • Background
    • Methods
    • Results
    • Conclusion
  • Please add the above headings (Background, Methods, Results, Conclusion) to each section of your abstract body. These headings will not count towards your word limit of 400.

Step 4. Preview & Submit

  • Please proofread your submission prior to submitting.
  • Once an abstract is submitted it cannot be deleted, modified or corrected in the system after submission. All submitted abstracts will be published exactly as submitted.
  • Any abstracts in “Draft” status after the submission deadline has passed will not be considered for review. It is the abstract submitters responsibility to ensure that all abstracts you wish to be reviewed have been properly submitted.
  • Should you need to withdraw a submitted abstract, please contact naclc2022-program at icsevents.com. Please include the abstract number and abstract title in your email.
  • Please carefully review the affiliation of all your co-authors as this is how it will appear in the conference program book as well as on the conference website.
  • You will be asked to review and agree to the abstract submission terms & conditions prior to submitting your abstract. Please read the information carefully.

For inquiries, please contact [email protected]. If your inquiry is regarding a particular draft or submission, please include the abstract number and title in your email.

For any program and abstract related questions, please contact [email protected].